Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TIMM8AP1 (translocase of inner mitochondrial membrane 8A pseudogene 1) is a pseudogene and does not encode a functional protein. It is not a therapeutic target or a functional biomolecule, but is related by sequence to TIMM8A (deafness-dystonia peptide 1), which encodes a mitochondrial protein essential for the import of other proteins into the mitochondrial inner membrane. Mutations in TIMM8A, not TIMM8AP1, cause Mohr–Tranebjærg syndrome (also known as deafness-dystonia syndrome). TIMM8AP1 is listed as a pseudogene in major gene databases, with no evidence of encoding a protein or being involved in biological processes or disease directly. It should not be confused with the disease-relevant target TIMM8A.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Translocase of inner mitochondrial membrane 8A pseudogene 1 (TIMM8AP1).